Memantine had an advantage to be able to improve astrocytic reactivity in type 1 DM and Arc expression in both types of diabetes, which may spark a future therapeutic role of the NMDARs antagonists in diabetes-associated cognitive dysfunction. The gene discussed is ARC; the disease is diabetes mellitus.